Table 3.

Deaths prevented or postponed by medical and surgical treatments in the West Bank in 2009

			Coronary heart disease deaths prevented or postponed			Proportion of overall deaths prevented or postponed (%)
Treatments	Patients eligible	Treatment uptake (%)	Best estimate	Minimum estimate	Maximum estimate
Acute myocardial infarction	489		2	1	6	−1.9
Hospital resuscitation		0.06	0	0	1	−0.3
Thrombolysis and aspirin
Aspirin alone		0.90	5	2	9	−3.8
Thrombolysis alone		0.39	3	1	6	−2.4
β-Blockers		0.58	1	0	2	−0.6
ACE inhibitors		0.44	1	0	2	−1
Secondary preventionpostinfarction	2266		9	4	30	−7.4
Aspirin		0.483	4	1	9	−2.9
β-Blockers		0.388	4	1	11	−3.6
Aspirin and β-blockers		0.415	4	1	10	−3.4
ACE inhibitors		0.472	5	2	13	−4.2
Statins		0.046	0	0	1	−0.4
Warfarin		0.100	1	0	3	−0.9
Rehabilitation		0.483	1	0	3	−0.9
Secondary preventionpostrevascularisation	208		2	0	6	− 1.9
Angina			7	6	13	−5.7
Coronary Artery Bypass Grafting surgery (2004–2005)	208	1	6	3	10	−4.6
Aspirin in the community	22180	0.47	15	13	40	−12.7
Statin in the community	22180	0.46	20	11	50	−16.8
Unstable angina	489		1	2	9	−1.1
Heart failure	2811
Hospital patients	468		−2	−1	−8	−1.5
Community patients	2342		−7	−4	−4	−5.4
Hypertension treatments			−5	−2	−23	−4.1
Total treatment effects			35	20	108	29